Clinical Scorecard: Alterations in Gut Microbiota Linked to Obesity in Adolescents with Type 1 Diabetes
At a Glance
Category
Detail
Condition
Obesity in adolescents with type 1 diabetes (T1D)
Key Mechanisms
Gut microbiome composition changes including increased Prevotella to Bacteroides ratio, altered bacterial taxa abundance, upregulated branched-chain amino acid biosynthesis, and elevated stool short-chain fatty acids
Target Population
Adolescents aged 11-18 years with type 1 diabetes, categorized as lean (BMI 5%-<85%) or obese (BMI ≥95%)
Care Setting
Pediatric diabetes clinics and outpatient settings
Key Highlights
Obesity in T1D youth is associated with distinct gut microbiome signatures including higher Prevotella copri abundance and altered metabolic pathways.
Obese T1D adolescents show increased stool short-chain fatty acids compared to lean counterparts.
Gut microbiome alterations in obese T1D youth may contribute to insulin resistance and diabetes complications.
Guideline-Based Recommendations
Diagnosis
Assess BMI percentile to categorize lean versus obese in adolescents with T1D.
Consider stool microbiome analysis to identify gut microbial composition and metabolite profiles associated with obesity in T1D.
Management
Target gut microbiome alterations as a potential therapeutic approach to manage obesity in T1D.
Monitor and address insulin sensitivity and inflammation related to obesity in T1D patients.
Monitoring & Follow-up
Regularly monitor BMI and glycemic control (HbA1c) in adolescents with T1D.
Evaluate gut microbiome changes and short-chain fatty acid levels as emerging biomarkers for obesity-related complications.
Risks
Obesity in T1D increases risk for insulin resistance, higher insulin requirements, chronic inflammation, hypoglycemia, dyslipidemia, and long-term diabetes complications.
Patient & Prescribing Data
Adolescents with type 1 diabetes, stratified by BMI status (lean vs obese)
Gut microbiome-targeted therapies may be beneficial in managing obesity and its metabolic consequences in T1D; current data support further research into microbiome modulation.
Clinical Best Practices
Screen adolescents with T1D for obesity using standardized BMI percentiles.
Consider the role of gut microbiota and microbial metabolites in the pathophysiology of obesity in T1D.
Avoid recent antibiotic or immunosuppressant use before microbiome assessment to reduce confounding effects.
Incorporate multidisciplinary approaches including nutrition, endocrinology, and microbiome research for comprehensive obesity management in T1D.
by Heba M Ismail, Dimuthu Perera, Rabindra Mandal, Linda A DiMeglio, Carmella Evans-Molina, Tamara Hannon, Joseph Petrosino, Sara Javornik Cregeen, Nathan W Schmidt
Researchers found that patients with higher waist circumference and lower grip strength had the greatest risk for developing type 2 diabetes during long-term follow-up.
